Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Possible link between androgens and COVID-19 severity; more research needed.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Maidenhair fern might help with COVID-19 symptoms, but it needs more testing.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.